Meeting
2017 Genitourinary Cancers Symposium
Relationships between an androgen receptor output signature (ARoS), AR expression, and poor prostate cancer prognosis in RP tissues.
Authors
Mohammed Alshalalfa
GenomeDx Biosciences, Vancouver, BC, Canada
Mohammed Alshalalfa , Maria Santiago-Jimenez , Nicholas Erho , Nicholas Fishbane , Kasra Yousefi , Hussam Al-Deen Ashab , Elai Davicioni , Ashley Ross , Edward M. Schaeffer
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Localized Disease
Citation
J Clin Oncol 35, 2017 (suppl 6S; abstract 38)
DOI
10.1200/JCO.2017.35.6_suppl.38
Abstract #
38
Poster Bd #
C1
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
A phase 3 study of androgen annihilation in high-risk biochemically relapsed prostate cancer: An Alliance Foundation trial (AFT-19).
First Author: Rahul Raj Aggarwal
Poster
2023 ASCO Genitourinary Cancers Symposium
Effect of neoadjuvant stereotactic body radiation therapy (SBRT) on the immune microenvironment of high-risk localized prostate cancer in paired transcriptomic analysis of pretreatment biopsy and irradiated prostatectomy specimens.
First Author: Ariel E. E. Marciscano
Poster
2023 ASCO Genitourinary Cancers Symposium
Evaluating p53 nuclear expression and prostate cancer progression in a predominantly African American cohort.
First Author: William Gesztes
Poster
2023 ASCO Genitourinary Cancers Symposium
Therapeutic potential of plant-derived nanovesicles for neuroendocrine prostate cancer.
First Author: Sharanjot Saini